Outcomes of hospitalizations for cardiogenic shock at left ventricular assist device vs non–left ventricular assist device centers
Journal of the American Heart Association Dec 06, 2020
Wang JI, Lu DY, Feldman DN, et al. - This study was intended to distinguish individuals with cardiogenic shock (CS) in the 2012 to 2014 National Inpatient Sample. Researchers examined the clinical characteristics, revascularization rates, and use of mechanical circulatory support in left ventricular assist device (LVAD) vs non‐LVAD centers. Multivariable logistic regression models were applied to examine the relationship between hospital type and in‐hospital mortality. In this study, 26.0% were in LVAD centers out off 272,075 hospitalizations. This study’s findings revealed that the risk‐adjusted mortality was lower in patients with CS who were hospitalized at LVAD centers. According to the findings, these centers likely represent specialized, shock team capable institutions across the country that may be best suited to manage individuals with CS.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries